Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice

Opioid use disorder (OUD) is a cause of significant morbidity and mortality in the United States. Although efforts are being made to limit access to prescription opioids, the use of heroin and synthetic opioids as well as death due to opioid overdose has increased. Medication-assisted treatment (MAT...

Бүрэн тодорхойлолт

-д хадгалсан:
Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Mark Deyo-Svendsen (Зохиогч), Matthew Cabrera Svendsen (Зохиогч), James Walker (Зохиогч), Andrea Hodges (Зохиогч), Rachel Oldfather (Зохиогч), Meghna P. Mansukhani (Зохиогч)
Формат: Ном
Хэвлэсэн: SAGE Publishing, 2020-06-01T00:00:00Z.
Нөхцлүүд:
Онлайн хандалт:Connect to this object online.
Шошгууд: Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_71eeb7e6b7b64d97b203b0a9bc83149f
042 |a dc 
100 1 0 |a Mark Deyo-Svendsen  |e author 
700 1 0 |a Matthew Cabrera Svendsen  |e author 
700 1 0 |a James Walker  |e author 
700 1 0 |a Andrea Hodges  |e author 
700 1 0 |a Rachel Oldfather  |e author 
700 1 0 |a Meghna P. Mansukhani  |e author 
245 0 0 |a Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice 
260 |b SAGE Publishing,   |c 2020-06-01T00:00:00Z. 
500 |a 2150-1327 
500 |a 10.1177/2150132720931720 
520 |a Opioid use disorder (OUD) is a cause of significant morbidity and mortality in the United States. Although efforts are being made to limit access to prescription opioids, the use of heroin and synthetic opioids as well as death due to opioid overdose has increased. Medication-assisted treatment (MAT) is the pairing of psychosocial intervention with a Food and Drug Administration (FDA)-approved medication (methadone, buprenorphine plus naltrexone) to treat OUD. MAT has resulted in reductions in overdose deaths, criminal activity, and infectious disease transmission. Access to MAT in rural areas is limited by shortages of addiction medicine-trained providers, lack of access to comprehensive addiction programs, transportation, and cost-related issues. Rural physicians express concern about lack of mentorship and drug diversion as reasons to avoid MAT. The prescribing of MAT with buprenorphine requires a Drug Enforcement Agency (DEA) waiver that can easily be obtained by Family Medicine providers. MAT can be incorporated into the outpatient practice, where patient follow-up rates and number needed to treat to effect change are similar to that of other chronic medical conditions. We describe a case of opioid overdose and a suggested protocol for the induction of MAT with buprenorphine/naloxone (Suboxone) for OUD in a rural family medicine outpatient practice. Treatment access is facilitated by utilizing the protocol, allowing office staff work to the extent allowed by their licensure, promoting teamwork and minimizing physician time commitment. We conclude that improved access to MAT can be accomplished in a rural family medicine outpatient clinic by staff that support and mentor one another through use of a MAT protocol. 
546 |a EN 
690 |a Computer applications to medicine. Medical informatics 
690 |a R858-859.7 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Journal of Primary Care & Community Health, Vol 11 (2020) 
787 0 |n https://doi.org/10.1177/2150132720931720 
787 0 |n https://doaj.org/toc/2150-1327 
856 4 1 |u https://doaj.org/article/71eeb7e6b7b64d97b203b0a9bc83149f  |z Connect to this object online.